Beta-Blockers for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: An Updated Meta-Analysis of Randomized Clinical Trials
Aim. Cardiotoxicity is a well-recognized complication of chemotherapy with Anthracyclines. However, results from trials evaluating beta-blockers for prevention are controversial. Therefore, we performed a meta-analysis to find whether prophylactic administration of beta-blockers can help prevent Ant...
Saved in:
Main Authors: | Armin Attar (Author), Arman Karimi Behnagh (Author), Mehrasa Hosseini (Author), Foad Amanollahi (Author), Paria Shafiekhani (Author), Ali Kabir (Author) |
---|---|
Format: | Book |
Published: |
Hindawi-Wiley,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
by: Yingxu Ma, et al.
Published: (2019) -
Updates in Anthracycline-Mediated Cardiotoxicity
by: Canan G. Nebigil, et al.
Published: (2018) -
A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity
by: Xinyu Yang, et al.
Published: (2018) -
An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity
by: Sicong Xie, et al.
Published: (2024) -
Beta-blockers in cardiac arrhythmias-Clinical pharmacologist's point of view
by: Łukasz Wołowiec, et al.
Published: (2023)